RCTs is an international full-service CRO located in Lyon (France) which has been supporting pharmaceutical firms, medical device companies and academic sponsors for over 30 years in their research projects.
Our team specialized in medical devices also supports you in the regulatory and clinical development of your device as well as in its clinical evaluation (CEP, CER and PMCFP), in accordance with European Regulation 2017/745.
+800
Completed projects
50/50
We process as many pre-authorization studies as post-authorization
50%
Of the studies we conduct are international
40/440
40 employees in France / 440 worldwide
The expertise of our teams covers all therapeutic areas, all types of study (interventional and non-interventional), whether data are collected, or secondary data are assessed.
RCTs has been co-founder and shareholder of PSNResearch since 2011 with four other European and one American CROs. This international CRO enable our company to pilot large-scale international trials with extensive geographic coverage through its 14 offices: America (North & South) and Europe with over 400 employees.
Created in 1989, RCTs was the first university spin-off in France resulting from the know-how of the Clinical Pharmacology Unit of Lyon 1 University. It was one of the first CROs in Europe. This precedence and origins naturally give us knowledge transmission values and proven expertise. While fostering – on a daily basis – a team spirit and conviviality, the quality of our services based on transparency and trust positions us today as a benchmark CRO in France.
Knowledge transmission Transparency Expertise Trust Team spirit
Our president
Oncology 
Neurology 
Pulmonology 
Rheumatology 
Transplantation 
Food 
Cardiovasculaire 
Dermatology 
Diabetes 
Gastroenterology 
Haematology 
Immunology 
Infectious diseases